Akers Biosciences Inc Share Price (AKR)

0.00 0.00 (0.00%) delayed: 1:34AM BST
Bid price 17.00 Open price 0.00
Ask price 22.00 Prev close 19.50
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Akers Biosciences Inc share prices, Akers Biosciences Inc stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Akers Biosciences Inc Level 2 Data, indepth research tools and investor commentary for Akers Biosciences Inc (AKR) and other London Stock Exchange equities.

Akers Biosciences Inc Share Price Chart

Advanced Charts >>

Register now for FREE Akers Biosciences Inc share price charts

Akers Biosciences Inc Share Price Information

Name Akers Biosciences Inc Epic AKR
Sector Health Care Equipment & Services ISIN US00973E1029
Activites Akers Biosciences, Inc. develops, manufactures, and supplies rapid screening and testing products designed to deliver quicker and more cost-effective healthcare information to healthcare providers and consumers. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical product distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics. Index n/a

Akers Biosciences Inc Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 12.26
Market Capitalisation (£m) 17.73 Gross Gearing (%) 16.29
Shares in issue (m) 90.94 Debt Ratio 0.00
P/E Ratio -0.32 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.20
Dividend Yield (%) 0.00 Price to book value 1.95
Dividend cover (x) 0.00 ROCE (%) -63.71
Earning per share (p) -61.00 EPS Growth (%) 0.00
52 week high / low 100.00 / 15.00 DPS Growth (%) n/a

Akers Biosciences Inc Director Deals

Dec.Date Type Director Pos No. of Shares
23/07/2013 TOUT Dr Raymond Akers RES 7,000,000

More Akers Biosciences Inc Director Deals >>

Akers Biosciences Inc Company News

13:40 03/07/2018

Akers Biosciences inks six new sales partnerships in the US

Health-related IT group Akers Biosciences said it had inked agreements with six more organisations to further expand sales in the US of its rapid test for heparin-induced thrombocytopenia. The so-called independent sales representatives, or ISR, agreements were signed withStone Mountain...

12:00 03/07/2018

Independent Sales Representative Agreements - PIFA

RNS Number : 3929T Akers Biosciences, Inc. 03 July 2018   July 3, 2018  Akers Biosciences, Inc.   Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test   Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("...

07:30 02/07/2018

Suspension - Akers Bioscience, Inc

RNS Number : 0978T AIM 02 July 2018         NOTICE   02/07/2018 7:30am   TEMPORARY SUSPENSION OF TRADING ON AIM   AKERS BIOSCIENCES, INC   Trading on AIM for the under-mentioned securities has been temporarily suspended from 02/07/2018...

More Akers Biosciences Inc Company News >>

Register now for FREE Akers Biosciences Inc company news

Akers Biosciences Inc Share Price Discussions

more than 1 year ago

Akers: Up, Up & Away (AKR)

Some good news for the end of the week: Thorofare, NJ, USA - September 9, 2005 Akers Biosciences, Inc. (LSE: AKR) is delighted to announce the final conclusion to the legal matter, which had been pending in the United States District Court, Southern District of Florida since February, 2004. On...

Register now for FREE Akers Biosciences Inc share price discussions